Cargando…
EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients
Background: Due to the insufficient understanding of the biological mechanisms, the improvement of therapeutic effects of prostate cancer (PCa) is limited. There is an urgent need to find the molecular mechanisms and underlying PCa to improve its early diagnosis, treatment, and prognosis. Methods: T...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065552/ https://www.ncbi.nlm.nih.gov/pubmed/35517503 http://dx.doi.org/10.3389/fcell.2022.843604 |